PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

Progyny, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$27.84+0.98 (+3.65%)

Close on Oct 19, 2026

Market cap: $2.29B
P/E (TTM): 30.3
Dividend yield: –

Progyny, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Depreciation & Amortization	4.95	3.18	2.28	1.60	1.30	1.91	2.13	1.88	1.56
Stock-Based Compensation	132	128	123	101	34	13	5.06	3.00	1.56
Deferred Income Taxes	-8.12	-10	3.75	-6.61	-33	-38	0.01	-1.78	0.00
Change in Accounts Receivable	-5.12	-9.87	-22	-119	-69	-35	-25	-13	-2.04
Change in Accounts Payable	29	-30	16	48	18	25	3.50	10	-0.91
Operating Cash Flow	210	179	189	80	26	36	-1.53	2.27	-9.47
Capital Expenditures	-18	-5.41	-3.64	-3.24	-2.13	-1.04	-2.96	-0.58	-0.61
Acquisitions	-9.34	-5.30	0	0	–	–	–	–	–
Purchase of Investments	-355	-170	-430	-163	-111	-104	–	–	–
Sale & Maturity of Investments	224	377	233	123	122	65	–	–	–
Investing Cash Flow	-159	196	-201	-44	8.77	-40	-2.76	1.90	-0.61
Share Repurchases	-82	-300	0	0	–	–	-0.19	-1.21	–
Taxes Paid on Share-Based Awards	-16	-12	-17	-12	-18	-8.93	–	–	–
Financing Cash Flow	-99	-310	-11	-7.86	-14	-6.25	85	-8.74	12
Foreign Exchange Rate Adjustments	0.06	0.00	0.00	0	0	–	–	–	–
Net Change in Cash	-48	65	-23	29	21	-10	–	–	–
Free Cash Flow	192	174	185	77	24	35	-4.49	1.69	-10
Income Taxes Paid	55	40	6.18	0.13	0.10	0	–	–	–
Interest Paid	–	–	–	–	–	–	0.18	0.51	0.54

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 24.6%
Operating margin: 8.6%
Net margin: 6.0%
Return on equity, FY2025: 12.5%

Financial strength

Current ratio: 2.14
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 63.6%

Valuation

P/E ratio: 30.3
Price to sales: 1.74
Price to book: 5.05
Dividend yield: –